oxytocin and Brain-Ischemia

oxytocin has been researched along with Brain-Ischemia* in 4 studies

Other Studies

4 other study(ies) available for oxytocin and Brain-Ischemia

ArticleYear
Oxytocin improves ischemic stroke by reducing expression of excitatory amino acid transporter 3 in rat MCAO model.
    Journal of immunoassay & immunochemistry, 2021, Sep-03, Volume: 42, Issue:5

    Various molecular mechanisms are activated in neurons during ischemic stroke. Extracellular glutamate secretion into brain tissue causes neurotoxicity and brain damage. Excitatory amino acid transporter 3 (EAAT3) could remove the extracellular glutamate. Neuroprotective activity of oxytocin (OT) in ischemia of various tissues has been reported. This study investigates the neuroprotective effect of OT in an animal model of middle cerebral artery occlusion (MCAO) and the possible role of EAAT3. Transient MCAO was performed as a model of ischemic stroke in male rats and then OT was administrated intra-nasally. Infarct volume was measured by 2, 3, 5-triphenyl tetrazolium chloride staining. Nissl staining method was performed for the evaluation of neuronal cell morphology. Immunohistochemistry assay was performed to analyze the EAAT3 expression in the ischemic region. OT significantly reduced the infarct volume in the cerebral cortex and striatum after ischemia (

    Topics: Animals; Brain Ischemia; Disease Models, Animal; Excitatory Amino Acid Transporter 3; Glutamates; Infarction, Middle Cerebral Artery; Ischemic Stroke; Male; Oxytocin; Rats; Stroke

2021
Oxytocin mediates social neuroprotection after cerebral ischemia.
    Stroke, 2011, Volume: 42, Issue:12

    The reduced incidence, morbidity, and mortality of stroke among humans with strong social support have been well-documented; however, the mechanisms underlying these socially mediated phenomena remain unknown, but may involve oxytocin (OT), a hormone that modulates some aspects of social behavior in humans and other animals.. In the present study, adult male mice were socially isolated (housed individually) or socially paired (housed with an ovariectomized female); social pairing increased hypothalamic OT gene expression. To determine whether a causal relationship exists between increased OT and improved stroke outcome, mice were treated with exogenous OT or OT receptor antagonist beginning 1 week before induction of experimental stroke via middle cerebral artery occlusion.. Relative to social isolation, social housing attenuated infarct size, neuroinflammation, and oxidative stress following experimental stroke; the neuroprotective effect of social housing was eliminated by receptor antagonist treatment. In contrast, administration of OT to socially isolated mice reproduced the neuroprotection conferred by social housing. We further report evidence for a direct suppressive action of OT on cultured microglia, which is a key instigator in the development of neuroinflammation after cerebral ischemia.. These findings support the hypothesis that OT mediates the neuroprotective effect of social interaction on stroke outcome.

    Topics: Animals; Brain; Brain Ischemia; Female; Hormone Antagonists; Housing, Animal; Hypothalamus; Male; Mice; Oxytocin; Receptors, Oxytocin; Social Behavior; Social Isolation

2011
"Won't you be my neighbor?": deciphering the mechanisms of neuroprotection induced by social interaction.
    Stroke, 2011, Volume: 42, Issue:12

    Topics: Animals; Brain; Brain Ischemia; Female; Male; Oxytocin; Social Behavior; Social Isolation

2011
Enhanced pressor responses to ICV vasopressin after pretreatment with oxytocin.
    The American journal of physiology, 1994, Volume: 266, Issue:2 Pt 2

    The role of oxytocin (OT) in the modulation of arginine vasopressin (AVP)-induced cardiovascular effects within the central nervous system was investigated in urethan-anesthetized rats. Intracerebroventricular injection of AVP (1-10 pmol) produced dose-dependent increases in mean arterial pressure (MAP) and heart rate (HR). These responses were enhanced in rats pretreated 24 h earlier with OT (10 pmol icv). The enhanced cardiovascular effects of AVP in OT-pretreated animals were dose dependent, blocked by the V1 antagonist d(CH2)5Tyr(Me)AVP, not evoked by OT alone, and occurred in the absence of changes in basal (nonstimulated) MAP and HR. In addition, central administration of AVP in OT-pretreated rats, but not in saline-pretreated controls, caused dose-dependent oscillations of the MAP and HR responses and, at higher doses, death of the animals. The enhanced cardiovascular actions of centrally injected AVP in OT-pretreated rats do not appear to be secondary to skeletal muscle contractions or the result of cerebral ischemia. Our data point to an interaction between the central oxytocinergic and vasopressinergic systems in cardiovascular control.

    Topics: Animals; Arginine Vasopressin; Blood Pressure; Brain; Brain Ischemia; Cerebral Ventricles; Cerebrovascular Circulation; Heart Rate; Injections, Intraventricular; Male; Muscle Contraction; Oxytocin; Rats; Rats, Sprague-Dawley; Regional Blood Flow

1994